Skip to content
  • LIPOEDEME (L&M n°2 2026)
  • SUMMARY
  • EDITORIALS
  • PRATIQUES
  • ACTUALITÉS
  • RECHERCHE
  • VALEURS
  • ARCHIVES L&M
Icône L&M 2L&M 2
  • LIPOEDEME (L&M n°2 2026)
  • SUMMARY
  • EDITORIALS
  • PRATIQUES
  • ACTUALITÉS
  • RECHERCHE
  • VALEURS
  • ARCHIVES L&M
  • SCLÉROTHÉRAPIE (L&M n°3 2026)
  • EVF Phlebology Leaders
  • PIL Papers
  • Industry Leaders
  • Contact
Icône L&M 3L&M 3
  • SCLÉROTHÉRAPIE (L&M n°3 2026)
  • EVF Phlebology Leaders
  • PIL Papers
  • Industry Leaders
  • Contact
  • LIPOEDEME (L&M n°2 2026)
  • SUMMARY
  • EDITORIALS
  • PRATIQUES
  • ACTUALITÉS
  • RECHERCHE
  • VALEURS
  • ARCHIVES L&M
Icône L&M 2L&M 2
  • LIPOEDEME (L&M n°2 2026)
  • SUMMARY
  • EDITORIALS
  • PRATIQUES
  • ACTUALITÉS
  • RECHERCHE
  • VALEURS
  • ARCHIVES L&M
  • SCLÉROTHÉRAPIE (L&M n°3 2026)
  • EVF Phlebology Leaders
  • PIL Papers
  • Industry Leaders
  • Contact
Icône L&M 3L&M 3
  • SCLÉROTHÉRAPIE (L&M n°3 2026)
  • EVF Phlebology Leaders
  • PIL Papers
  • Industry Leaders
  • Contact

Mots-clés: MOLÉCULE ENDOGÈNE

LM N°2/ 2024. The state of the art in 2024. HYALURONIC ACID, FROM THE ENDOGENOUS MOLECULE TO INJECTABLE GELS. Denis COUCHOUREL.

Denis Couchourel, PhD

The state of the art in 2024 HYALURONIC ACID: FROM ENDOGENIC MOLECULE TO INJECTABLE GELS Denis COUCHOUREL, PhD Scientific and Medical Director, Laboratoires VIVACY ENDOGENIC HYALURONIC ACID In 1934, Karl Meyer and John Palmer described a new polysaccharide initially isolated from bovine vitreous humor. This substance contained a uronic acid and a sugar [...].

  • TO BE A LEADER IN ANTI-AGING MEDICINE
  • QUALITY COMMUNICATION 
  • INNOVATIVE VISUAL OFFERS
  • STRONG DIGITAL COMMUNICATION FOR MANUFACTURERS
  • AN ORIGINAL AND SCIENTIFIC MULTIMEDIA EXPERTISE
  • THE L&M BRAND: A REFERENCE FOR AESTHETIC HEALTH PROFESSIONALS

Useful links

  • Contact
  • CGU
  • Blog

Social networks

Instagram Facebook-f

Website and mobile application designed by CAPROVE